Citation: H. Silver, REDBRICK-UNIVERSITY REVISITED - THE AUTOBIOGRAPHY OF TRUSCOT,BRUCE - PEERS,EA, MACKENZIE,AL, ALLAN,AR, Studies in higher education, 23(1), 1998, pp. 105-106
Citation: H. Silver et N. Shmugliakov, AUGMENTATION WITH FLUVOXAMINE BUT NOT MAPROTILINE IMPROVES NEGATIVE SYMPTOMS IN TREATED SCHIZOPHRENIA - EVIDENCE FOR A SPECIFIC SEROTONERGIC EFFECT FROM A DOUBLE-BLIND-STUDY, Journal of clinical psychopharmacology, 18(3), 1998, pp. 208-211
Citation: M. Oconnor et H. Silver, ADDING RISPERIDONE TO SELECTIVE SEROTONIN REUPTAKE INHIBITOR IMPROVESCHRONIC DEPRESSION, Journal of clinical psychopharmacology, 18(1), 1998, pp. 89-91
Authors:
ALI NM
BOCTOR RN
SILVER H
BEHARI L
CHOI Y
Citation: Nm. Ali et al., INABILITY OF MULTIPLE TRANSFUSED AIDS PATIENT TO PRODUCE ANTI-D AND OTHER NON ABO RED-CELLS ANTIBODIES, Transfusion, 38(10), 1998, pp. 156-156
Authors:
SILVER H
BARASH I
SHMUGLIAKOV N
ODNOPOZOV N
Citation: H. Silver et al., THE EFFECT OF CHRONIC FLUVOXAMINE TREATMENT ON OVERNIGHT MELATONIN SECRETION IN MEDICATED CHRONIC-SCHIZOPHRENIC PATIENTS, Human psychopharmacology, 12(1), 1997, pp. 21-25
Citation: H. Silver et R. Bures, DUAL CITIES - SECTORAL SHIFTS AND METROPOLITAN INCOME INEQUALITY, 1980-90, Service industries journal, 17(1), 1997, pp. 69-90
Authors:
HERSH EM
NABEL G
SILVER H
RINEHART J
STAHL S
Citation: Em. Hersh et al., INTRATUMORAL INJECTION OF PLASMID DNA IN CATIONIC LIPID VECTORS FOR CANCER GENE-THERAPY, Cancer gene therapy, 3(6), 1996, pp. 1-1
Citation: H. Silver, THE EFFECT OF SSRI AUGMENTATION OF ANTIPSYCHOTICS IN THE TREATMENT OFNEGATIVE SYMPTOMS, Schizophrenia research, 18(2-3), 1996, pp. 4-4
Authors:
GOODWIN TM
VALENZUELA G
SILVER H
HAYASHI R
CREASY GW
LANE R
Citation: Tm. Goodwin et al., TREATMENT OF PRETERM LABOR WITH THE OXYTOCIN ANTAGONIST ATOSIBAN, American journal of perinatology, 13(3), 1996, pp. 143-146
Citation: H. Silver, HIDDEN IN THE HOME - THE ROLE OF WAGED HOMEWORK IN THE MODERN WORLD-ECONOMY - DANGLER,JF, Work and occupations, 23(1), 1996, pp. 121-122
Citation: H. Silver et N. Geraisy, AMANTADINE DOES NOT EXACERBATE POSITIVE SYMPTOMS IN MEDICATED, CHRONIC-SCHIZOPHRENIC PATIENTS - EVIDENCE FROM A DOUBLE-BLIND CROSSOVER STUDY, Journal of clinical psychopharmacology, 16(6), 1996, pp. 463-464
Authors:
GOODWIN TM
VALENZUELA GJ
SILVER H
CREASY G
Citation: Tm. Goodwin et al., DOSE-RANGING STUDY OF THE OXYTOCIN ANTAGONIST ATOSIBAN IN THE TREATMENT OF PRETERM LABOR, Obstetrics and gynecology, 88(3), 1996, pp. 331-336
Authors:
HANING RV
SEIFER DB
WHEELER CA
FRISHMAN GN
SILVER H
PIERCE DJ
Citation: Rv. Haning et al., EFFECTS OF FETAL NUMBER AND MULTIFETAL REDUCTION ON LENGTH OF IN-VITRO FERTILIZATION PREGNANCIES, Obstetrics and gynecology, 87(6), 1996, pp. 964-968
Citation: H. Silver et al., FLUVOXAMINE AUGMENTATION IN CLOZAPINE-RESISTANT SCHIZOPHRENIA - AN OPEN PILOT-STUDY, Biological psychiatry, 40(7), 1996, pp. 671-674
Citation: H. Silver et al., PSYCHOTIC SYMPTOMS IN SCHIZOPHRENICS DURING CHRONIC FLUVOXAMINE TREATMENT - A REPORT OF 2 CASES, Schizophrenia research, 16(1), 1995, pp. 77-79
Citation: H. Silver et al., CHRONIC FLUVOXAMINE TREATMENT REDUCES PLATELET MAO ACTIVITY IN MEDICATED CHRONIC-SCHIZOPHRENICS, Human psychopharmacology, 10(4), 1995, pp. 321-326
Citation: H. Silver et al., FLUVOXAMINE AUGMENTATION IN CHRONIC-SCHIZOPHRENIA - AN OPEN EXPLORATORY-STUDY, Human psychopharmacology, 10(1), 1995, pp. 59-63
Citation: H. Silver et al., NO DIFFERENCE IN THE EFFECT OF BIPERIDEN AND AMANTADINE ON PARKINSONIAN-TYPE AND TARDIVE-DYSKINESIA-TYPE INVOLUNTARY MOVEMENTS - A DOUBLE-BLIND CROSSOVER, PLACEBO-CONTROLLED STUDY IN MEDICATED CHRONIC-SCHIZOPHRENIC PATIENTS (VOL 56, PG 167, 1995), The Journal of clinical psychiatry, 56(9), 1995, pp. 435-435